Filing Flows › MiniMed Group (MMED) › Q1 2026 › vs Q1 2025
MiniMed Group (MMED) Q1 2026 vs Q1 2025 (year over year)
MiniMed Group's revenue rose $113M (+16%) from $724M in Q1 2025 to $837M in Q1 2026.
MiniMed Group, Q1 2026: revenue $837M (+16% year over year), operating margin -11.1%, net loss $185M, operating cash flow −$170M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $837M | $724M | $113M | +16% |
| Net loss | $185M | $168M | $17.0M | +10% |
| Costs & expenses | $1.0B | $893M | $130M | +15% |
| Operating costs | $930M | $872M | $58.0M | +7% |
| Income tax | $93.0M | $21.0M | $72.0M | +343% |
| Cost of revenue | $357M | $319M | $38.0M | +12% |
| Research & development | $99.0M | $107M | −$8.0M | -7% |
| SG&A | $299M | $276M | $23.0M | +8% |
| Other operating costs | $175M | $170M | $5.0M | +3% |
| Operating cash sources | $217M | −$36.0M | $253M | — |
| Depreciation & amortization | $39.0M | $38.0M | $1.0M | +3% |
| Share-based compensation | $8.0M | $9.0M | −$1.0M | -11% |
| Cash used in operations | $170M | −$83.0M | $253M | — |
| Net loss absorbed | $185M | $168M | $17.0M | +10% |
| Working capital & other | $32.0M | −$204M | $236M | — |
Questions
How much did MiniMed Group's revenue grow year over year in Q1 2026?
MiniMed Group's revenue rose $113M (+16%) from $724M in Q1 2025 to $837M in Q1 2026.